These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8470675)

  • 1. Possible incompatibilities with immune globulin for i.v. use.
    Hazlet TK; Tankersley DL
    Am J Hosp Pharm; 1993 Apr; 50(4):654, 659-60. PubMed ID: 8470675
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune globulin and the shortage of plasma derivatives.
    Tecnologica; 1999 Feb; ():1, 3-8, 10. PubMed ID: 10848145
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility.
    Huizing K; Røislien J; Hansen T
    Acta Paediatr; 2008 Oct; 97(10):1362-5. PubMed ID: 18616629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Government investigates ongoing shortage of i.v. immune globulin.
    Am J Health Syst Pharm; 1998 Jul; 55(13):1341-2, 1344. PubMed ID: 9659960
    [No Abstract]   [Full Text] [Related]  

  • 5. Availability of immune globulin intravenous for treatment of immune deficient patients--United States, 1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Mar; 48(8):159-62. PubMed ID: 10079062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune globulin intravenous products--notice to hospitals.
    Hogan V
    CMAJ; 1999 Apr; 160(7):1051-2, 1055-6. PubMed ID: 10207352
    [No Abstract]   [Full Text] [Related]  

  • 7. Blocking i.v. drug incompatibilities.
    Trissel LA
    Nursing; 1993 Jun; 23(6):74. PubMed ID: 8510845
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immune globulin for multiple sclerosis.
    Tecnologica MAP Suppl; 1998 Aug; ():3-5. PubMed ID: 10342975
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immune globulin for recurrent fetal loss.
    Tecnologica; 1995 Nov; ():7-8. PubMed ID: 10168306
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immune globulin for recurrent spontaneous abortion.
    Tecnologica MAP Suppl; 1998 May; ():11-3. PubMed ID: 10184996
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immune globulin for multiple sclerosis.
    Tecnologica; 1995 May; ():10. PubMed ID: 10168292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGIV: contents, properties, and methods of industrial production--evolving closer to a more physiologic product.
    Martin TD
    Int Immunopharmacol; 2006 Apr; 6(4):517-22. PubMed ID: 16504913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nurse's role in administration of intravenous immunoglobulin therapy.
    Kirmse J
    Home Healthc Nurse; 2009 Feb; 27(2):104-11; quiz 112-3. PubMed ID: 19212223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of immune globulin intravenous (human) to prevent infection in the multiple trauma patient.
    Bianchine PJ
    Crit Care Med; 2000 Jan; 28(1):254-5. PubMed ID: 10667535
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous therapy. 4. The meaning of incompatibility; specific group incompatibilities.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Apr; 101(4):87-8. PubMed ID: 5907995
    [No Abstract]   [Full Text] [Related]  

  • 16. Respiratory syncytial virus immune globulin intravenous (human) receives marketing approval in Canada.
    Langley JM
    Can Fam Physician; 1998 Jan; 44():113. PubMed ID: 9481469
    [No Abstract]   [Full Text] [Related]  

  • 17. Infant botulism in the age of botulism immune globulin.
    Thompson JA; Filloux FM; Van Orman CB; Swoboda K; Peterson P; Firth SD; Bale JF
    Neurology; 2005 Jun; 64(12):2029-32. PubMed ID: 15917401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of immune globulins.
    Tepper M; Gully P
    Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
    [No Abstract]   [Full Text] [Related]  

  • 19. Does Canada face a crisis? US considers ending plasma exports.
    Sibbald B
    CMAJ; 1998 Jun; 158(12):1639-41. PubMed ID: 9645181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmaceutic incompatibilities--undesirable drug conditions--in mixed feed medications. I. Physical incompatibilities].
    Telser E
    Dtsch Tierarztl Wochenschr; 1978 Dec; 85(12):483-8. PubMed ID: 363398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.